ARMISTICE CAPITAL LLC 13D and 13G filings for Unicycive Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:18 pm Unchanged | 2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | ARMISTICE CAPITAL LLC | 976,000 2.730% | 0 (Unchanged) | Filing |
| 2023-02-14 1:41 pm Purchase | 2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | ARMISTICE CAPITAL LLC | 976,000 6.080% | 176,000 (+22.00%) | Filing |
| 2022-02-14 9:37 pm Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | ARMISTICE CAPITAL LLC | 800,000 5.100% | 800,000 (New Position) | Filing |